CLINICAL_TRIALS
trial_result
· 2023-03-22
Clinical Trial Update: Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study [Phase 3]
Summary
A Phase 3 effectiveness study evaluating reconsolidation blockade for trauma-related disorders after Paris attacks in PTSD patients, completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Post-traumatic Stress Disorder | Phase 3 | Status: COMPLETED